IP Verse

Novo Nordisk Health Care competitive analysis

Latest patents of Novo Nordisk Health Care opposed by its competitors

Explore Novo Nordisk Health Care's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 3, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP1517698
Dec 6, 2017Stabilised Solid Compositions Of Factor Vii Polypeptides1
EP1673452
Dec 23, 2015Method For Large-Scale Production Of A Polypeptide In Eukaryote Cells And A Culture Vessel Suitable Therefor1
EP2625262
Sep 23, 2015Process For Protein Production1
EP2059527
Dec 3, 2014Modified Proteins1
EP2201111
Aug 13, 2014Reduction Of Dimer Content In Factor Vii Polypeptide Compositions By Heat Treatment1
EP1711513
Jul 2, 2014Nanofiltration Of Factor Vii Solutions To Remove Virus2

Latest PTAB cases involving Novo Nordisk Health Care

Discover the latest PTAB cases involving Novo Nordisk Health Care, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Novo Nordisk Health Care with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 3, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
NOVO NORDISK HEALTH CARE - 7 - -
BAXALTA2026 - -
BAXTER1447515
LABORATOIRE FRANCAIS DU FRACTIONNEMENT DES BIOTECHNOLOGIES3 - 1 -